Avidity Biosciences (NASDAQ:RNA) Earns Outperform Rating from Analysts at Wolfe Research
Equities research analysts at Wolfe Research assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $55.00 price target on the biotechnology company’s stock. Wolfe Research’s price objective points to a potential upside of 87.59% from […]
Equities research analysts at Wolfe Research assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research note issued on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $55.00 price target on the biotechnology company’s stock. Wolfe Research’s price objective points to a potential upside of 87.59% from […]
